Low Immunity Linked to Poor Outcomes in Patients with HIV, COVID-19
January 13th 2021As patients with HIV are living longer, they are also being diagnosed with chronic conditions that have become increasingly common in recent decades, putting them at higher risk of COVID-19 hospitalization and death.
Read More
Researchers from the University of Texas MD Anderson Cancer Center found that men with localized prostate cancer who reported a baseline dietary pattern that more closely follows the key principles of a Mediterranean-style diet fared better over the course of their disease.
Read More
Monoclonal Antibodies Show Promise Treating COVID-19
There is particular interest in monoclonal antibody agents to determine whether their immune suppressive effects can reduce the immediate and long-term impact of COVID-19.
Read More
Study: Biologic Therapy for Psoriasis May Reduce Heart Disease
January 12th 2021The current study provides characterization of a lipid-rich necrotic core, a dangerous type of coronary plaque made up of dead cells and cell debris that is prone to rupture, which can lead to a heart attack or stroke.
Read More
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA Approval by FDA
January 12th 2021Amneal Pharmaceuticals, Inc announced that it has received approval of an additional strength of 500 mg to its Abbreviated New Drug Application from the FDA for Abiraterone Acetate tablets.
Read More
Supreme Court Ruling May Open the Door for More Widespread Legislation Limiting Power of PBMs
January 11th 2021Katea Ravega, a partner at Quarles and Brady LLP, discussed the recent Supreme Court ruling in Rutledge v. PCMA and what it could mean for the future of states’ legislation around PBMs.
Read More
Physician-Pharmacist Collaboration May Increase Adherence to Opioid Addiction Treatment
January 11th 2021A pilot study published today in Addiction found that a collaborative approach to treating opioid use disorder that relies heavily on community pharmacists is feasible and may increase adherence and participant satisfaction.
Read More
Facebook Posts Help Facilitate Belief that HPV Vaccine is Dangerous to Health
January 11th 2021When examining the percentage of posts that made the vaccine seem more dangerous, less dangerous, or neither, Luisi found nearly 40% of Facebook posts about the HPV vaccine amplified a perceived risk.
Read More
Risankizumab Demonstrates Significant Improvements In Patients with Crohn Disease
January 11th 2021A significantly greater proportion of patients with Crohn disease achieved both primary endpoints with overall safety results generally consistent with the known safety profile of risankizumab.
Read More